Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.

van der Straten A, Montgomery ET, Cheng H, Wegner L, Masenga G, von Mollendorf C, Bekker L, Ganesh S, Young K, Romano J, Nel A, Woodsong C.

AIDS Behav. 2012 Oct;16(7):1775-86.

PMID:
22644068
2.

Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use.

Montgomery ET, van der Straten A, Cheng H, Wegner L, Masenga G, von Mollendorf C, Bekker L, Ganesh S, Young K, Romano J, Nel A, Woodsong C.

AIDS Behav. 2012 Oct;16(7):1787-98.

PMID:
22790902
3.

User experiences and acceptability attributes of the diaphragm and lubricant gel in an HIV prevention trial in southern Africa.

Sahin-Hodoglugil NN, Montgomery E, Kacanek D, Morar N, Mtetwa S, Nkala B, Philip J, Ramjee G, Cheng H, van der Straten A, The Mira Team.

AIDS Care. 2011 Aug;23(8):1026-34. doi: 10.1080/09540121.2010.543879.

PMID:
21480005
4.

Sexuality, HIV risk and potential acceptability of involving adolescent girls in microbicide research in Kisumu, Kenya.

Montandon M, Sahin-Hodoglugil NN, Bukusi E, Agot K, Boland B, Cohen CR.

Sex Health. 2008 Dec;5(4):339-46.

PMID:
19061553
5.

Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.

Vallely A, Fitzgerald L, Fiya V, Aeno H, Kelly A, Sauk J, Kupul M, Neo J, Millan J, Siba P, Kaldor JM.

BMC Res Notes. 2012 Nov 1;5:613. doi: 10.1186/1756-0500-5-613.

6.

Changes in sexual behavior during a safety and feasibility trial of a microbicide/diaphragm combination: an integrated qualitative and quantitative analysis.

Guest G, Johnson L, Burke H, Rain-Taljaard R, Severy L, von Mollendorf C, Van Damme L.

AIDS Educ Prev. 2007 Aug;19(4):310-20.

PMID:
17685844
7.

A qualitative study of obstacles to diaphragm and condom use in an HIV prevention trial in sub-Saharan Africa.

Kacanek D, Dennis A, Sahin-Hodoglugil NN, Montgomery ET, Morar N, Mtetwa S, Nkala B, Phillip J, Watadzaushe C, van der Straten A; Mira Team.

AIDS Educ Prev. 2012 Feb;24(1):54-67. doi: 10.1521/aeap.2012.24.1.54.

PMID:
22339145
9.

Acceptability of Praneem polyherbal vaginal tablet among HIV uninfected women & their male partners in Pune, India--Phase I study.

Joglekar NS, Joshi SN, Navlakha SN, Katti UR, Mehendale SM.

Indian J Med Res. 2006 Apr;123(4):547-52.

PMID:
16783046
10.

The acceptability of an investigational vaginal microbicide, PRO 2000 Gel, among women in a phase I clinical trial.

Morrow K, Rosen R, Richter L, Emans A, Forbes A, Day J, Morar N, Maslankowski L, Profy AT, Kelly C, Abdool Karim SS, Mayer KH.

J Womens Health (Larchmt). 2003 Sep;12(7):655-66.

PMID:
14583106
11.

Acceptability of vaginal film, soft-gel capsule, and tablet as potential microbicide delivery methods among African women.

Nel AM, Mitchnick LB, Risha P, Muungo LT, Norick PM.

J Womens Health (Larchmt). 2011 Aug;20(8):1207-14. doi: 10.1089/jwh.2010.2476. Epub 2011 Jul 20.

PMID:
21774672
12.

The role of partnership dynamics in determining the acceptability of condoms and microbicides.

Montgomery CM, Lees S, Stadler J, Morar NS, Ssali A, Mwanza B, Mntambo M, Phillip J, Watts C, Pool R.

AIDS Care. 2008 Jul;20(6):733-40. doi: 10.1080/09540120701693974.

PMID:
18576176
13.

Degrees of disclosure: a study of women's covert use of the diaphragm in an HIV prevention trial in sub-Saharan Africa.

Sahin-Hodoglugil NN, van der Straten A, Cheng H, Montgomery ET, Kacanek D, Mtetwa S, Morar N, Munyoro J, Padian N; MIRA Team.

Soc Sci Med. 2009 Nov;69(10):1547-55. doi: 10.1016/j.socscimed.2009.08.014. Epub 2009 Sep 16.

PMID:
19765879
14.

Acceptability of a microbicide among women and their partners in a 4-country phase I trial.

Bentley ME, Fullem AM, Tolley EE, Kelly CW, Jogelkar N, Srirak N, Mwafulirwa L, Khumalo-Sakutukwa G, Celentano DD.

Am J Public Health. 2004 Jul;94(7):1159-64.

15.

Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".

Montgomery ET, van der Straten A, Stadler J, Hartmann M, Magazi B, Mathebula F, Laborde N, Soto-Torres L.

AIDS Behav. 2015 May;19(5):784-93. doi: 10.1007/s10461-014-0950-5.

16.

To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.

Kelly CA, Friedland BA, Morar NS, Katzen LL, Ramjee G, Mokgatle MM, Ahmed K.

Cult Health Sex. 2015;17(8):1004-20. doi: 10.1080/13691058.2015.1030451. Epub 2015 Apr 27.

PMID:
25913101
17.

Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.

Lanham M, Wilcher R, Montgomery ET, Pool R, Schuler S, Lenzi R, Friedland B.

J Int AIDS Soc. 2014 Sep 8;17(3 Suppl 2):19159. doi: 10.7448/IAS.17.3.19159. eCollection 2014.

18.

Acceptability of the female condom among STD clinic patients.

el-Bassel N, Krishnan SP, Schilling RF, Witte S, Gilbert L.

AIDS Educ Prev. 1998 Oct;10(5):465-80.

PMID:
9799941
19.

Women's interest in vaginal microbicides.

Darroch JE, Frost JJ.

Fam Plann Perspect. 1999 Jan-Feb;31(1):16-23.

20.

Safety, Acceptability and Adherence of Dapivirine Vaginal Ring in a Microbicide Clinical Trial Conducted in Multiple Countries in Sub-Saharan Africa.

Nel A, Bekker LG, Bukusi E, HellstrÓ§m E, Kotze P, Louw C, Martinson F, Masenga G, Montgomery E, Ndaba N, van der Straten A, van Niekerk N, Woodsong C.

PLoS One. 2016 Mar 10;11(3):e0147743. doi: 10.1371/journal.pone.0147743. eCollection 2016.

Supplemental Content

Support Center